Transabdominal Ultrasonography as a Screening Test for Second-Trimester Placenta Previa

Quant, Hayley S. MD; Friedman, Alexander M. MD; Wang, Eileen MD; Parry, Samuel MD; Schwartz, Nadav MD

doi: 10.1097/AOG.0000000000000129
Contents: Original Research

OBJECTIVE: To determine the test characteristics of transabdominal ultrasonography as a screening test for second-trimester placenta previa.

METHODS: This secondary analysis of a prospective cohort study evaluated the distance from the placental edge to the internal os (placenta–cervix distance) through both transabdominal and transvaginal ultrasonography during the anatomic survey. Patients were recruited in the Maternal-Fetal Medicine Ultrasound Unit at the Hospital of the University of Pennsylvania, an urban tertiary care center. Transabdominal placenta–cervix distance cutoffs with high sensitivity for detection of previa and low-lying placenta were identified, and test characteristics were calculated. Follow-up ultrasound data, pregnancy, and delivery outcomes for those with second-trimester previa or low-lying placenta were obtained.

RESULTS: One thousand two hundred fourteen women were included in the analysis. A transabdominal placenta–cervix distance cutoff of 4.2 cm was 93.3% sensitive and 76.7% specific for detection of previa with a 99.8% negative predictive value at a screen-positive rate of 25.0%. A cutoff of 2.8 cm was 86.7% sensitive and 90.5% specific with a 99.6% negative predictive value at a screen-positive rate of 11.4%. Only 9.8% (four of 41) of previas and low-lying placentas persisted through delivery.

CONCLUSION: Transabdominal ultrasonography is an effective screening test for second-trimester placenta previa. At centers not performing universal transvaginal ultrasonography at the time of the anatomic survey, evidence-based transabdominal placenta–cervix distance cutoffs can optimize the identification of patients who require further surveillance for previa.

LEVEL OF EVIDENCE: II

Transabdominal ultrasound screening can be used to identify patients who require transvaginal ultrasound assessment for second-trimester placenta previa.

Maternal and Child Health Research Program, Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, New York.

Corresponding author: Hayley S. Quant, MD, 3400 Spruce Street, 2000 Courtyard, Philadelphia, PA 19104; e-mail: Hayley.Quant@uphs.upenn.edu.

The authors thank the following sonographers for their work on this study: Deb Riesch, Sue Betsch, Cynthia Ross, Dénenne Paquin, and Carmen Fund; the authors also thank Jamie A. Bastek, MD, MSCE, and Suchitra Chandrasekaran, MD, for their statistical support.

Presented at the American Institute of Ultrasound in Medicine 2013 Annual Convention, April 6–10, 2013, New York, New York.

Financial Disclosure The authors did not report any potential conflicts of interest.

© 2014 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.